Milk Thistle.

NAC supplies cysteine, the limiting building block the body uses to make glutathione, while milk thistle's silymarin helps sustain the liver's glutathione and antioxidant defenses. Both feed the same system hepatocytes use to neutralize the reactive byproducts of normal metabolism.

Silymarin's flavonolignans bind non-heme iron in the gut, so taking milk thistle alongside an iron dose can lower how much of that iron is absorbed. Spacing the two a few hours apart keeps iron uptake from being blunted.

Silymarin is absorbed poorly because gut and liver cells quickly pump it back out through efflux transporters. Piperine from black pepper slows those transporters, so more silymarin stays in circulation, the same bioenhancer effect it lends other hard-to-absorb plant compounds.

Both are plant polyphenols that activate Nrf2, the switch that prompts the body to make more of its own antioxidant enzymes. Paired in liver-support formulas, they reinforce that same normal defensive response through overlapping routes.

Silybin is poorly water soluble and poorly absorbed on its own, so the phospholipid complex is the standard way it is delivered. Phosphatidylcholine forms that complex.

Selenium is built into glutathione peroxidase, the enzyme that spends glutathione to reduce peroxides. Silymarin supports glutathione availability, so the pairing covers both the substrate and the enzyme.

Dihydrolipoic acid regenerates other antioxidants and supports cysteine availability for glutathione synthesis. That complements silymarin's role in maintaining glutathione status.

Silymarin's main described action is preserving cellular glutathione, and supplemental glutathione feeds the same pool from the other end. The two act on one molecule from supply and sparing sides.

Artichoke cynarin promotes bile secretion and flow while silymarin acts on hepatocyte membranes and glutathione status. The two actions do not overlap.

Dandelion root sesquiterpene lactones stimulate bile production, a different action from silymarin's membrane and glutathione effects.

Tocopherol stops lipid peroxidation chains inside membranes, a phase silymarin reaches only partly. The two cover the aqueous and lipid compartments of the same tissue.

Ascorbate reduces the tocopheroxyl radical back to active tocopherol at the membrane surface, keeping the antioxidant network turning over. Silymarin contributes to the same network through glutathione.

Schisandra lignans influence phase one and phase two enzyme expression, while silymarin acts on membranes and glutathione. The actions do not duplicate.

Taurine conjugates bile acids, which keeps them soluble and moving. That downstream step complements silymarin's support of hepatocyte glutathione.

SAM-e feeds the transsulfuration route that converts homocysteine to cysteine, the rate limiting amino acid for glutathione synthesis. Silymarin acts on how that glutathione is preserved.

Silymarin flavonolignans are poorly water soluble, which is the limiting step in how much reaches circulation. A 2026 report describes a krill oil-based formulation of milk thistle extract and measures its uptake in laboratory models with a human arm reported alongside. Uptake is a pharmacokinetic marker, not an outcome, and the finding belongs to that specific formulation rather than to krill oil generally.

Complexing silybin with phospholipid is the classic route to improving its solubility, and lecithin supplies the phosphatidylcholine that forms the complex. The interaction is chemical rather than physiological: the phospholipid changes how the molecule partitions, not what it does. A loose blend of lecithin and extract is not the same thing as a manufactured complex.

Sunflower-derived lecithin provides the same phosphatidylcholine chemistry as the soy-derived material, and is used where a soy-free label is wanted. Its role is as a solubilising vehicle for a poorly soluble flavonolignan. Source of the lecithin does not change the underlying complexation.

Poorly soluble plant constituents are absorbed better from a lipid vehicle because the lipid triggers bile release and forms mixed micelles that carry the compound across the unstirred water layer. Medium-chain triglycerides are used as that vehicle in softgels. The effect is on delivery, not on activity.

Choline is the head group of phosphatidylcholine, and phosphatidylcholine is required to package triglyceride into VLDL for export from the liver. That is normal lipid handling, a separate biochemistry from the flavonolignan chemistry of milk thistle. The two are combined for that complementarity rather than because they interact chemically.

Betaine donates a methyl group to convert homocysteine to methionine through betaine-homocysteine methyltransferase, an enzyme concentrated in liver tissue. Methionine feeds S-adenosylmethionine, which supplies the methyl groups for phosphatidylcholine synthesis. This is textbook one-carbon biochemistry standing beside, not overlapping with, silymarin chemistry.

Glutathione is a tripeptide of glutamate, cysteine and glycine, so glycine is one of the three required substrates. Cysteine is usually the limiting one, which makes glycine a supporting rather than a rate-setting input. Pairing it with milk thistle rests on this synthesis pathway, not on a combination study.

Sulforaphane modifies cysteine residues on KEAP1, releasing Nrf2 to drive transcription of phase II enzymes including glutathione S-transferases. Silymarin constituents have also been described as touching the same transcriptional programme. Both statements are cell-level, and stacking two activators of one pathway is not automatically additive in a person.

Broccoli sprout material supplies glucoraphanin, the precursor that myrosinase converts to sulforaphane. It reaches the same phase II enzyme programme by the same route, one conversion step earlier. Conversion depends on plant or gut bacterial myrosinase activity and varies widely between people.

Silymarin flavonolignans and quercetin are both handled largely by UGT and sulfotransferase conjugation and both inhibit those enzymes to a degree in vitro. Taken together they compete for the same conjugation capacity, which can raise exposure to either. Filed as competitive so the direction is stated rather than assumed helpful.

Resveratrol undergoes extensive sulfation and glucuronidation and inhibits those enzymes at higher concentrations, the same conjugation route silymarin depends on. Stacking two heavily conjugated polyphenols loads a shared elimination pathway. The in vitro evidence for this is stronger than the human evidence.

Ubiquinol is the lipid-phase antioxidant of the inner mitochondrial membrane and is regenerated by the same reducing systems that maintain other cellular antioxidants. Milk thistle constituents act in a different compartment. The pairing is a coverage argument across compartments, not a measured synergy.

A 2026 poultry study examined a fenugreek, milk thistle and ginkgo additive together with a second thyme, cinnamon and oregano additive, so the combination has been fed and measured, in birds. The endpoints are physicochemical and production measures in poultry. Nothing there transfers to a person, and it is cited because the combination itself was studied.

The same poultry study paired a thyme, cinnamon and oregano additive alongside the milk thistle-containing one, with outcomes reported at the level of meat physicochemical measures. This is livestock nutrition and the combination is a feed formulation. It is recorded here as a co-studied pairing, not as a human recommendation.

Two 2026 veterinary reports combine probiotic and herbal complexes containing milk thistle and measure health status, mineral composition and growth measures in animals. The herbal component is one part of a multi-ingredient complex in both. The pairing is documented in livestock, and the endpoints do not read across to people.

Zinc is the catalytic metal in alcohol dehydrogenase and in copper-zinc superoxide dismutase, both enzymes of hepatic and cytosolic metabolism. That is cofactor biochemistry sitting beside, not overlapping with, flavonolignan chemistry. No combination evidence is cited for the pairing.

Magnesium is required by the ATP-dependent ligases of glutathione synthesis and by hundreds of other transferases. It supports the machinery that any glutathione-directed approach depends on. This is general cofactor biochemistry rather than a specific interaction with silymarin.

Riboflavin becomes FAD, the cofactor of glutathione reductase, which is the enzyme that regenerates reduced glutathione from its oxidised form. Without adequate flavin the recycling step slows. This is settled biochemistry and needs no combination trial to state.